Share

EndoCares: DC a Success

This past Saturday, November 17, the Endocrine Society held its second iteration of EndoCares: DC, its global outreach program for healthcare providers, patients, and the general public. This year, EndoCares followed a health fair format focused on diabetes awareness, and it was held simultaneously at the Mexican and Peruvian consulates, a first for the program...
Share

Persistent Organic Pollutants May Affect Child Growth and Development through Placental Thyroid Hormones

Exposure to persistent organic pollutants (POPs) is associated with thyroid hormone (TH) levels in placenta, which could explain how exposure to these chemicals affects child growth and development, according to a study recently published in Endocrinology. Researchers led by Zhong-Min Li, MSc, and Meri De Angelis, PhD, both of Helmholtz Zentrum München-German Research Center for...
Share

Constructive Disruption in Diabetes

In its inaugural event, the Disrupt Diabetes Design Challenge brought together new perspectives to tackle persistent challenges diabetes with a human-first, design-centric approach. A mechanical engineer is sitting in a conference room at Stanford University. At the table, he is joined by an emergency medicine clinical pharmacist and healthcare designer. Across from them sit two...
Share

Advocacy in Action: Midterms, Fetal Tissue Research, Diabetes, and More

What’s Happening in Washington Election Aftermath – Congress returned to Capitol Hill to begin the post-election lame duck session, a laundry list of unfinished business awaits, including seven remaining fiscal 2019 spending measures. While leaders of both parties remain hopeful, political jostling could grind the processes to a halt and force another shutdown showdown just...
Share

Advocacy in Action: Election Results, EDCs, Diabetes Awareness, and More

What’s Happening in Washington Election Results – While Republicans held onto the majority in the US Senate, Democrats picked up more than the 23 seats needed to gain control of the House of Representatives when the 116th Congress convenes in January.  The Democrats’ win of the House will portend serious changes in Washington, as the...
Share

Analysis Estimates the Positive Impact of Empagliflozin on Life Expectancy in Adults with Type 2 Diabetes and Established Cardiovascular Disease

Treatment with empagliflozin may positively impact life expectancy in adults with type 2 diabetes and established cardiovascular disease, according to results from the EMPA-REG OUTCOME trial recently published in Circulation. Using actuarial methods and assuming that the demonstrated beneficial effects of empagliflozin remain consistent with long-term use, empagliflozin was estimated to extend life expectancy by one...